Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
83.45
-2.04 (-2.39%)
At close: Sep 11, 2026, 4:00 PM EDT
85.50
+2.05 (2.46%)
After-hours: Sep 11, 2026, 7:46 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.08 billion as of September 11, 2026. Its market cap has increased by 72.08% in one year.
Market Cap
4.08B
Enterprise Value
4.08B
1-Year Change
72.08%
Ranking
Category
Stock Price
$83.45
ChartMarket Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.08B, an increase of 2,949.57%. That is a compound annual growth rate of 46.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.08B | -11.52% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parabilis Medicines | 4.56B |
| Relay Therapeutics | 4.14B |
| Veradermics | 4.13B |
| Tango Therapeutics | 4.01B |
| Enliven Therapeutics | 3.98B |
| Iovance Biotherapeutics | 3.90B |
| Telix Pharmaceuticals | 3.82B |
| Viking Therapeutics | 3.73B |